BR9713587A - Derivados de ácido 4-(1-piperazinil) benzóico, processo para preparação dos mesmos e suas aplicações terapêuticas - Google Patents

Derivados de ácido 4-(1-piperazinil) benzóico, processo para preparação dos mesmos e suas aplicações terapêuticas

Info

Publication number
BR9713587A
BR9713587A BR9713587-9A BR9713587A BR9713587A BR 9713587 A BR9713587 A BR 9713587A BR 9713587 A BR9713587 A BR 9713587A BR 9713587 A BR9713587 A BR 9713587A
Authority
BR
Brazil
Prior art keywords
benzoic acid
therapeutic applications
derivatives
piperazinyl
preparing
Prior art date
Application number
BR9713587-9A
Other languages
English (en)
Inventor
Gerard Moinet
Gerard Botton
Liliane Doare
Micheline Kergoat
Didier Messangeau
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of BR9713587A publication Critical patent/BR9713587A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • C07D215/08—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms with acylated ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)

Abstract

Patente de Invenção:<B>"DERIVADOS DE áCIDO 4-(1-PIPERAZINIL) BENZóICO, PROCESSO PARA PREPARAçãO DOS MESMOS E SUAS APLICAçõES TERAPêUTICAS"<D>. A presente invenção refere-se aos compostos da fórmula (I) em que Ar, R~ 1~, R~ 2~, R~ 3~, R~ 4~, R~ 5~ e R~ 6~ têm os significados dados na reivindicação 1. Esses compostos são úteis no tratamento de diabetes.
BR9713587-9A 1996-12-18 1997-12-15 Derivados de ácido 4-(1-piperazinil) benzóico, processo para preparação dos mesmos e suas aplicações terapêuticas BR9713587A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9615588A FR2757158B1 (fr) 1996-12-18 1996-12-18 Nouveaux derives d'acide 4-(1-piperazinyl) benzoique, leur procede de preparation et leurs applications therapeutiques
PCT/EP1997/007046 WO1998027078A1 (en) 1996-12-18 1997-12-15 New 4-(1-piperazinyl)benzoic acid derivatives, process for preparing them and their therapeutic applications

Publications (1)

Publication Number Publication Date
BR9713587A true BR9713587A (pt) 2000-04-04

Family

ID=9498818

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9713587-9A BR9713587A (pt) 1996-12-18 1997-12-15 Derivados de ácido 4-(1-piperazinil) benzóico, processo para preparação dos mesmos e suas aplicações terapêuticas

Country Status (26)

Country Link
US (1) US6281215B1 (pt)
EP (1) EP0937054B1 (pt)
JP (1) JP2001506645A (pt)
KR (1) KR20000069544A (pt)
CN (1) CN1073102C (pt)
AR (1) AR013889A1 (pt)
AT (1) ATE218558T1 (pt)
AU (1) AU726640B2 (pt)
BR (1) BR9713587A (pt)
CA (1) CA2275346A1 (pt)
CZ (1) CZ218999A3 (pt)
DE (1) DE69713128T2 (pt)
DK (1) DK0937054T3 (pt)
ES (1) ES2178039T3 (pt)
FR (1) FR2757158B1 (pt)
HU (1) HUP0000586A3 (pt)
ID (1) ID23671A (pt)
NO (1) NO312896B1 (pt)
PL (1) PL334187A1 (pt)
PT (1) PT937054E (pt)
RU (1) RU2178786C2 (pt)
SK (1) SK282841B6 (pt)
TR (1) TR199901367T2 (pt)
UA (1) UA56206C2 (pt)
WO (1) WO1998027078A1 (pt)
ZA (1) ZA9711329B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2763334A1 (fr) * 1997-05-13 1998-11-20 Lipha Derives anthraniliques
GB0013346D0 (en) * 2000-06-01 2000-07-26 Glaxo Group Ltd Therapeutic benzamide derivatives
US6476046B1 (en) 2000-12-04 2002-11-05 Sepracor, Inc. Diazabicyclo[4.3.0]nonanes, and methods of use thereof
CN101417988B (zh) * 2007-10-24 2011-04-27 山东轩竹医药科技有限公司 双胍哌嗪类二肽酰肽酶ⅳ抑制剂
CN101781273B (zh) * 2009-01-21 2012-07-04 山东轩竹医药科技有限公司 含有胍基的二肽酰肽酶ⅳ抑制剂

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2346011A1 (fr) * 1976-02-02 1977-10-28 Orsymonde Acetanilido-piperazines
DE3139970A1 (de) * 1981-10-08 1983-04-28 Boehringer Mannheim Gmbh, 6800 Mannheim Neue carbonsaeurederivate, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
US5364849A (en) * 1989-04-22 1994-11-15 John Wyeth & Brother, Limited 1-[3 or 4-[1-[4-piperazinyl]]-2 arylpropionyl or butryl]-heterocyclic derivatives
FR2693722B1 (fr) 1992-07-16 1994-10-14 Meram Lab Dérivés de la N-cycloalkylpipérazine, procédé d'obtention et compositions pharmaceutiques les contenant.
GB9221931D0 (en) * 1992-10-17 1992-12-02 Wyeth John & Brother Ltd Piperazine derivatives
FR2707984B1 (fr) * 1993-07-23 1995-09-01 Adir Nouvelles pipérazines substituées, leur procédé de préparation et les compositions les contenant.
US5607936A (en) * 1994-09-30 1997-03-04 Merck & Co., Inc. Substituted aryl piperazines as neurokinin antagonists
IT1278960B1 (it) * 1995-02-24 1997-12-02 Elitas S N C Di Belluzzi Lino Macchina tamponatrice per impregnare superficialmente pelli o simili.
US5723475A (en) * 1995-02-28 1998-03-03 Suntory Limited Arylpiperidine and arylpiperazine derivatives and medicament containing the same

Also Published As

Publication number Publication date
HUP0000586A2 (hu) 2001-04-28
AU726640B2 (en) 2000-11-16
CN1245494A (zh) 2000-02-23
JP2001506645A (ja) 2001-05-22
ATE218558T1 (de) 2002-06-15
SK78599A3 (en) 2000-03-13
NO992968L (no) 1999-08-17
DE69713128T2 (de) 2003-03-20
TR199901367T2 (xx) 1999-10-21
DE69713128D1 (de) 2002-07-11
WO1998027078A1 (en) 1998-06-25
SK282841B6 (sk) 2002-12-03
FR2757158B1 (fr) 1999-04-02
NO312896B1 (no) 2002-07-15
EP0937054B1 (en) 2002-06-05
NO992968D0 (no) 1999-06-17
AR013889A1 (es) 2001-01-31
CA2275346A1 (en) 1998-06-25
UA56206C2 (uk) 2003-05-15
PT937054E (pt) 2002-11-29
FR2757158A1 (fr) 1998-06-19
KR20000069544A (ko) 2000-11-25
EP0937054A1 (en) 1999-08-25
ID23671A (id) 2000-05-11
DK0937054T3 (da) 2002-09-16
CN1073102C (zh) 2001-10-17
CZ218999A3 (cs) 1999-09-15
AU5758298A (en) 1998-07-15
ZA9711329B (en) 1998-06-24
US6281215B1 (en) 2001-08-28
RU2178786C2 (ru) 2002-01-27
ES2178039T3 (es) 2002-12-16
HUP0000586A3 (en) 2002-10-28
PL334187A1 (en) 2000-02-14

Similar Documents

Publication Publication Date Title
BR9916633A (pt) Benzopiranos e benzoxepinas, composições farmacêuticas compreendendo-as e processo de preparação
BR9916732A (pt) Derivados de ácido malÈnico, processo para a sua preparação, seu uso e composições farmacêuticas contendo-os (inibição da atividade do fator xa)
BR9808953A (pt) Composto, processo para tratar um distúrbio mediado pela ciclooxigenase-2 em um paciente, e, composição farmacêutica
BR9913592A (pt) Compostos, processo de preparação dos compostos, e, composições farmacêuticas
BRPI0411255A (pt) composto, composição farmacêutica, uso de um composto, métodos de tratar um distúrbio de um paciente, e, processo para a preparação de um composto
BRPI0406427A (pt) Processo para a preparação de roflumilast
BR0309964A (pt) Derivados anticonvulsivos de sulfamoto substituìdo
BR9307451A (pt) Composto, composição farmacêutica e processo para fabricação de composto
BR0115580A (pt) Derivados de 3-aroilindol e a utilizaçao dos mesmos como agonistas dos receptores cb2
BR0208489A (pt) Derivados de n-(arilsulfonil) beta-aminoácidos, comportando um grupo aminoetilado substituìdo, o respectivo processo de preparação e as composições farmacêuticas que os contêm
BR0009651A (pt) Composto, processo para a preparação de um composto, composição farmacêutica, uso de um composto, e, método para tratar artrite reumatóide e uma doença obstrutiva das vias aéreas
FI942075A0 (fi) Sappihappojohdannaisten tetratsolijohdannaisia, menetelmä niiden valmistamiseksi ja näiden yhdisteiden käyttö lääkeaineina
BR0113989A (pt) Compostos, composições farmacêuticas, processo para a preparação de uma composição farmacêutica, e, uso de pelo menos um dos compostos
BR0014804A (pt) Composto, formulação farmacêutica, uso de um composto, método de profilaxia ou tratamento de uma arritmia, e, processo para a preparação de um composto
BR0108694A (pt) Derivados de ácido malÈnico, processo para preparação dos mesmos, uso dos mesmos como inibidor de atividade do fator xa e composições farmacêuticas que contêm os mesmos
BR9910573A (pt) Compostos antipicornavirais, preparação e uso dos mesmos
BR0015147A (pt) Ciclopropanos como cgrp-antagonistas, medicamentos contendo os ditos compostos e processo para a produção dos mesmos
BR9007758A (pt) Processo para inibir o crescimento ou replicacao dos virus da imuno deficiencia humana,compostos,composto intermediario e formulacao farmaceutica para inibir o crescimento ou replicacao do hiv
DOP2002000512A (es) Sales de acido succinato de 5,7,14-triazatetraciclo [10.3.1.0² ¹¹.04,9] hexadeca-2 (11),3,5,7,9-pentaeno y composiciones farmaceuticas de las mismas
BR9912138A (pt) Compostos cìclicos úteis no tratamento de dislipidemia, aterosclerose e diabetes, composções farmacêuticas e processo para preparação
BR9713921A (pt) Composto, composição farmacêutica, processo para tógico capaz de ser modulado através da inibição do fator xa
BR9809234A (pt) Composto, composição farmacêutica, uso de um composto, processos para tratar ou prevenir doenças do sistema endocrinológico, para fabricar um medicamento, para preparar um composto e um conjunto, conjunto, e, uso do mesmo.
BR0206791A (pt) Composto, formulação farmacêutica, uso de um composto, método de profilaxia ou tratamento de uma arritmia, e, processo para a preparação de um composto
BR0309014A (pt) ácido(2-((2-alcóxi)-fenil)-ciclopent-1-enil)carbo e heterocìclico aromático e derivados
BR9915436A (pt) Certas caprolactamas substituìdas, composições farmacêuticas contendo as mesmas e seu uso no tratamento de tumores

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADES.